DE60238551D1 - Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven - Google Patents

Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven

Info

Publication number
DE60238551D1
DE60238551D1 DE60238551T DE60238551T DE60238551D1 DE 60238551 D1 DE60238551 D1 DE 60238551D1 DE 60238551 T DE60238551 T DE 60238551T DE 60238551 T DE60238551 T DE 60238551T DE 60238551 D1 DE60238551 D1 DE 60238551D1
Authority
DE
Germany
Prior art keywords
biologically active
repair
active peptides
laminin
kdi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60238551T
Other languages
English (en)
Inventor
Paeivi Liesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60238551D1 publication Critical patent/DE60238551D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60238551T 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven Expired - Lifetime DE60238551D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20012082A FI20012082A0 (fi) 2001-10-26 2001-10-26 Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
PCT/FI2002/000831 WO2003035675A1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves

Publications (1)

Publication Number Publication Date
DE60238551D1 true DE60238551D1 (de) 2011-01-20

Family

ID=8562134

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60238551T Expired - Lifetime DE60238551D1 (de) 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven

Country Status (10)

Country Link
US (3) US20040266991A1 (de)
EP (1) EP1438329B1 (de)
JP (1) JP4312054B2 (de)
AT (1) ATE490972T1 (de)
AU (1) AU2002336124B2 (de)
CA (1) CA2465245C (de)
DE (1) DE60238551D1 (de)
DK (1) DK1438329T3 (de)
FI (1) FI20012082A0 (de)
WO (1) WO2003035675A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029468A1 (de) * 2005-06-24 2006-12-28 Plt Patent & Licence Trading Ltd. Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
EP2153174A1 (de) * 2007-05-31 2010-02-17 The Hertz Corporation System und verfahren zur automatischen ausstellung einer bordkarte für einen reisenden bei der rückgabe eines mietwagens
US8008253B2 (en) * 2007-07-03 2011-08-30 Andrew Tasker Treatment for anxiety
WO2009114539A2 (en) * 2008-03-10 2009-09-17 University Of Louisville Research Foundation Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
GB201700529D0 (en) 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT276041B (de) * 1968-08-16 1969-11-10 Dragoco Gerberding Co Gmbh Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas
US3590722A (en) * 1969-06-09 1971-07-06 Samuel Leptrone Flavor injector device
HU185263B (en) 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FI922517A (fi) * 1992-05-29 1993-11-30 Paeivi Liesi Nervrepareringsmedel och dess anvaendning
GB9217316D0 (en) 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
GB9324473D0 (en) 1993-11-29 1994-01-12 Oxford Res Support Co Ltd Isolation of streptokinase by affinity chromatography
CN1159146A (zh) * 1995-07-26 1997-09-10 弗门尼舍有限公司 风味产品及其制备方法
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
GB2348426B (en) 1997-04-03 2001-06-27 California Inst Of Techn Enzyme-mediated modification of fibrin for tissue engineering
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
IL121191A0 (en) * 1997-06-29 1997-11-20 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
JP2003525916A (ja) 1999-04-22 2003-09-02 エイドゲントシッシュ テクニーシェ ホッシュール チューリッヒ モディファイドタンパク質マトリクス
DE20010297U1 (de) 2000-06-08 2000-08-31 ETH Zürich, Zürich Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden

Also Published As

Publication number Publication date
US20080249021A1 (en) 2008-10-09
US7741436B2 (en) 2010-06-22
US20050288231A1 (en) 2005-12-29
EP1438329B1 (de) 2010-12-08
FI20012082A0 (fi) 2001-10-26
WO2003035675A1 (en) 2003-05-01
AU2002336124B2 (en) 2008-07-03
EP1438329A1 (de) 2004-07-21
US7659255B2 (en) 2010-02-09
JP2005512979A (ja) 2005-05-12
JP4312054B2 (ja) 2009-08-12
DK1438329T3 (da) 2011-03-28
CA2465245A1 (en) 2003-05-01
CA2465245C (en) 2012-09-11
US20040266991A1 (en) 2004-12-30
ATE490972T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
CY1111120T1 (el) Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση
ATE314860T1 (de) Verwendung des copolymer-1 peptids sowie von damit verwandten peptiden und polypeptiden und von damit behandelten t-zellen zur neuroprotektion vor glutamattoxizitaet
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
DE69938507D1 (en) Fragment des "connective tissue growth factor" (ctgf)
DE69841030D1 (de) Apolipoprotein A-I Agonisten und deren Verwendung zur Behandlung dyslipidämischer Erkrankungen
HK1077518A1 (en) Peptides that modulate nerve growth factor (ngf) activity, their compositions and use
PL368912A1 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
NO20023387L (no) Nogo reseptormediert blokade av axonal vekst
ATE338062T1 (de) Neuronale, die exozytose hemmende peptide und diese enthaltende kosmetische und pharmazeutische zusammensetzungen
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
DE60238551D1 (de) Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven
ATE259652T1 (de) Neuronale verwendungen des bmp-11
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
ATE193305T1 (de) Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
EP0917535A4 (de) Neuroaktive peptide
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
MY140828A (en) Therapeutic uses of tri-, tetra-, penta-, and polypeptides
WO1999062931A3 (en) A cell density signal protein suitable for treatment of connective tissue injuries and defects
EP1714979A3 (de) Peptide für die Behandlung von Tumoren und anderen Zuständen, die das entfernen oder zerstören von Zellen erfordern
DE60221718D1 (de) Eine, ein peptid und ein pigment enthaltende zusammensetzung und deren verwendung zur hautbräunung
EP1847550A3 (de) Peptide zur effektiven Behandlung von Tumoren und anderen Bedingungen, die Zellentfernung oder- zerstörung erfordern
CY1111301T1 (el) Πολυπεπτιδια που προερχονται απο προδρομο πεπτιδιο αμυλοειδους (αρρ) και οι χρησεις αυτων
MX9800686A (es) Nueva proteina hmw humana mp52s.